Print

Michael Green named vice provost for strategic research initiatives

UMass Medical School Communications

February 07, 2019
  Michael Green, MD, PhD
 

Michael R. Green, MD, PhD

UMass Medical School has created the role of vice provost for strategic research initiatives to coordinate the strategic direction of the medical school’s research enterprise and named Michael R. Green, MD, PhD, the Lambi and Sarah Adams Chair in Genetic Research, to the post, effective immediately, according to an announcement by Terence R. Flotte, MD, executive deputy chancellor, provost and dean of the School of Medicine.

“Biomedical research is at the core of our mission to advance the health and well-being of the people of the commonwealth and the world,” Dean Flotte said. “Dr. Green has been a leader in our collaborative scientific community for many years and we are fortunate to have him as a colleague and member of the Medical School’s renowned scientific community. In this new role, he will guide our scientific community by leading the development of the major research initiatives, including those in neuroscience, RNA therapeutics, precision medicine and host defense, as outlined in the ongoing Pathways of Promise fundraising campaign.”

Green will continue to serve as chair of the Department of Molecular, Cell & Cancer Biology, director of the UMMS Cancer Center, and co-director of the Li Weibo Institute for Rare Diseases Research. In addition, he will continue to collaborate with Katherine Luzuriaga, MD, the UMass Memorial Health Care Chair in Biomedical Research, who in her role as UMMS vice provost for clinical and translational research and director of the UMass Center for Clinical and Translational Science, is responsible for defining strategic initiatives and providing operational support for all human subjects research.

A longtime investigator of the Howard Hughes Medical Institute, Green has been elected to three of the world’s most prestigious academies—the National Academy of Sciences (2014), the National Academy of Medicine (2015) and the American Academies of Arts and Sciences (2018). His own scientific career has been devoted to studying alterations in gene regulation that cause and impact cancer as well as a wide range of other human diseases.

Additional Resources
click to open search panel